SCHEDULE: Evogene Shareholder Backs Board Amid Director Election

Leon Recanati, a board member and significant shareholder, has disclosed an increased stake in Evogene Ltd. and declared his intention to vote in favor of the current board's nominees in an upcoming contested director election.

Summary

• Leon Recanati, a director of Evogene Ltd., has filed a Schedule 13D, increasing his beneficial ownership to 5.7% of the company's ordinary shares.
• The acquisition of 800,000 shares for approximately $400,000 occurred on August 4, 2026, at an average price of $0.50 per share.
• Recanati's total beneficial ownership includes 883,886 directly held shares and 10,950 shares underlying exercisable options.
• He intends to vote his shares in favor of the current board's director nominees at the upcoming 2026 Annual General Meeting (AGM) on September 4, 2026.
• Recanati believes the current board is executing a successful strategic plan and has demonstrated strong financial discipline.
• He opposes the slate of directors proposed by dissident shareholders, citing a lack of a comprehensive alternative strategy and the risk of disruption.
• Recanati reserves the right to acquire or dispose of additional shares in the future.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, indicating a significant shareholder's confidence and strategic alignment with the current board's direction, despite an upcoming contested election.

Positives

• Significant shareholder (Leon Recanati) demonstrates confidence by increasing stake and publicly supporting the current board.
• Recanati's support is based on the belief that the current board is executing a clear strategic plan with measurable results.
• The current board is perceived to have proactively evolved and shown strong capital allocation and financial discipline.
• The acquisition of shares was made at an attractive price point ($0.50 per share).

Negatives

• The company faces a contested director election at the upcoming AGM, indicating internal shareholder dissent.
• Dissident shareholders have proposed an alternative slate of directors, creating potential disruption.
• The dissident slate has not presented a comprehensive strategic alternative, according to Recanati.

Risks

• Potential disruption to the Issuer's current strategic plan if the dissident slate of directors is elected.
• Uncertainty surrounding the outcome of the contested director election at the AGM.
• The possibility of Recanati changing his plans or intentions regarding his shareholdings.

Future Outlook

Leon Recanati may acquire additional Ordinary Shares or other securities of the Issuer in the future, depending on market conditions and the Issuer's financial condition and prospects. He reserves the right to change his plans or intentions at any time.

Management Comments

• "The Reporting Person believes that the current board is executing a clear strategic plan that is delivering measurable results, has proactively evolved as the Issuer has transformed, and has demonstrated strong capital allocation and financial discipline."
• "On the other hand, the slate proposed by the dissident shareholders has not presented a comprehensive strategic alternative, despite having been given an opportunity by the current board to do so, and would furthermore create unacceptable disruption risk to the Issuer's current strategic plan, which has been producing positive results."

Industry Context

StockSavvy.ai notes that this filing occurs within the context of a contested board election, a common scenario in the agritech sector where strategic direction and capital allocation are critical for growth and innovation. Leon Recanati's public support for the incumbent board suggests a belief in the current strategy's efficacy in a competitive landscape.

Corporate Governance

Stakeholder Impact

• Shareholders: The outcome of the director election will impact the company's strategic direction and potentially its stock performance. Recanati's support for the current board may reassure some investors, while the dissident slate could attract others.
• Employees: A change in board leadership could lead to shifts in management or strategic priorities, affecting employee morale and job security.
• Management: The current board and management team are seeking to retain their positions and continue their strategic plan.

Next Steps

• Leon Recanati will vote his shares in favor of the current board's director nominees at the AGM on September 4, 2026.
• Recanati may acquire or dispose of additional Evogene securities in the future.

Key Dates

Recommendation

The filing indicates a significant shareholder's confidence in the current board and strategy, which is a positive signal. However, the contested election introduces uncertainty and potential disruption. A 'hold' recommendation reflects a balanced view, acknowledging the positive support while awaiting the resolution of the board election and its impact on the company's strategic execution.

Keywords

Evogene Ltd., Schedule 13D, Leon Recanati, Director Election, Shareholder Activism, Corporate Governance, Investment, Agri-tech